문제 › Should We Buy a Competitor? › Staffing & Recruitment
인수 실패는 가격보다 계약자 풀과 고객 장부 통합에서 훨씬 자주 발생하며, 그 기간 동안 redeployment rate 하락으로 발생하는 비용은 가장 추정하기 어려운 숫자입니다. staffing firms에 적용되는 질문은 일반적인 것과 다릅니다. 39 percent 마진의 계약 연장은 추가 4 point 마크업 인하 또는 redeployment가 48 percent로 떨어져 수익 7.8 million이 줄어들 수 있습니다. 따라서 49.3 percent gross margin을 무시한 답은 틀리기 쉽습니다. 분석은 revenue가 아니라 62 percent redeployment rate와 19.4 percent average contract mark-up부터 시작해야 합니다.
인수 실패는 가격보다 계약자 풀과 고객 장부 통합에서 훨씬 자주 발생하며, 그 기간 동안 redeployment rate 하락으로 발생하는 비용은 가장 추정하기 어려운 숫자입니다. staffing firms에 적용되는 질문은 일반적인 것과 다릅니다. 39 percent 마진의 계약 연장은 추가 4 point 마크업 인하 또는 redeployment가 48 percent로 떨어져 수익 7.8 million이 줄어들 수 있습니다. 따라서 49.3 percent gross margin을 무시한 답은 틀리기 쉽습니다. 분석은 revenue가 아니라 62 percent redeployment rate와 19.4 percent average contract mark-up부터 시작해야 합니다.
경쟁사 인수 근거는 대개 상대 고객 접근으로 combined permanent fill rate나 contract mark-up을 높이는 revenue synergies에 있지만, 그 효과는 느리거나 실현되지 않는 경우가 많습니다. 공유 contractor utilisation에서 오는 cost synergies는 더 예측 가능하지만, 49.3 percent gross margin과 19.4 percent average contract mark-up을 합산 물량에 다시 적용하면 모델이 가정한 것보다 작아집니다.
결과를 결정하는 숫자는 systems migration, recruiter attrition, 39 percent 마진 계약 연장에 대한 고객 혼란, 1년 이상 기존 장부에서 빠지는 경영진 주의 등 integration cost입니다. redeployment rate가 48 percent로 떨어져 revenue가 7.8 million 줄어드는 경우에도 양사 장부에 나타나지 않아 흔히 생략됩니다.
엄격한 버전은 revenue synergies가 전혀 실현되지 않고 62 percent redeployment rate와 41 percent permanent fill rate가 그대로 유지될 때 사업이 어떻게 보이는지, 다른 방식으로 더 저렴하게 만들거나 살 수 없는 것이 무엇인지를 묻습니다.
이 세 가지가 함께 나타날 때 특징입니다. 하나만으로는 보통 다른 곳을 가리킵니다.
✓ 교차 판매 목표는 상대 고객으로부터의 fill rate 상승으로 모델에 들어가지만, 양쪽 조달팀은 여전히 별개로 남습니다.
✓ 통합 단계는 계획에 있지만 contractor utilisation이나 55 million 계약 관련 revenue에 미치는 영향은 표시되지 않습니다.
✓ 기존 사업은 contract extensions 성장 정체를 보이며, 인수를 volume 회복 경로로 제시합니다.
보통 상황을 더 악화시키는 조치입니다. combined permanent placement와 contract mark-up에서 오는 revenue synergies로 딜을 평가하는 것. 이는 보통 늦게, 모델보다 작게, 또는 전혀 오지 않습니다.
It is for you if you run or finance a staffing firm and the rationale leans on cross-selling to each other's customers. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on a staffing firm. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Northgate Talent Partners, a sample company profile used for testing rather than a customer — 84.6 million dollars total revenue with 55 million from contracts.
Excerpt from a real Percision run · Quick Market Scan · sample company profile
The move. Turn Northgate’s redeployment data into a legally binding 14-day SLA that locks 39–42 % gross margin for 24 months.
| Investment required | $0.55–0.85 M over 18 months — fully funded inside the $1.2 M FY2026 cap by reallocating 4 existing FTEs and modest analytics tooling ($75 k). |
| Expected return | Base case: $2.4–3.1 M incremental gross profit over 36 months on $0.85 M investment (2.8–3.6×). |
| Revenue, year 1 | $1.1–1.4 M incremental contract revenue (39 % GM on extensions) |
| Revenue, year 2 | $2.3–2.9 M cumulative |
| Revenue, year 3 | $3.6–4.5 M cumulative |
| Exit criteria | Program should be abandoned if, by Month 12, fewer than 4 of the 12 targeted accounts have signed SLAs OR if the redeployment rate has not risen above 64 % by Month 18, OR if any single top-10 enterprise account (currently 44 % of contract revenue) is lost during the renewal cycle. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Growth Portfolio Framework, one of 29 engagements the platform runs. For staffing firms it works through 49.3 percent gross margin, 62 percent redeployment rate, 19.4 percent average contract mark-up and 41 percent permanent fill rate, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 전체 보고서 읽기 if you would rather see the depth first.
두 번 산정합니다. standalone 가치와 귀사에 특별히 가치 있는 금액. 그 차이가 가치 창출을 유지하면서 지불할 수 있는 최대 금액이며, 보통 예상보다 좁습니다.
cost synergies입니다. 통제 가능하고 일정 잡을 수 있습니다. revenue synergies는 고객이 모델처럼 행동한다는 가정에 의존하며, 이는 가장 자주 틀리는 전제입니다.
통합에 예산보다 많은 경영진 주의가 소모되어, 딜이 상환되어야 할 기간 동안 양쪽 사업 모두 실적이 저하되는 경우입니다.
Materially, yes. Contract extensions at 39 percent margin face further 4 point mark-up cuts or redeployment falls to 48 percent cutting revenue 7.8 million — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 49.3 percent gross margin, 62 percent redeployment rate, 19.4 percent average contract mark-up, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 49.3 percent gross margin and 62 percent redeployment rate. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית